These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33997604)

  • 1. The use of eculizumab as a bridge to retransplantation for chronic antibody-mediated rejection in a heart transplant recipient: a case report.
    Kearney K; Macdonald P; Hayward C; Muthiah K
    Eur Heart J Case Rep; 2021 May; 5(5):ytab180. PubMed ID: 33997604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
    Schwotzer N; Paganetti G; Barchi M; Perrottet N; Aubert V; Sadallah S; Rotman S; Venetz JP; Matter M; Golshayan D; Pascual M
    Xenotransplantation; 2020 Jul; 27(4):e12630. PubMed ID: 32698246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.
    Yerly P; Rotman S; Regamey J; Aubert V; Aur S; Kirsch M; Hullin R; Pascual M
    Xenotransplantation; 2022 Jan; 29(1):e12726. PubMed ID: 35001433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated rejection with detection of
    Ludwig B; Schneider J; Föll D; Zhou Q
    Eur Heart J Case Rep; 2020 Feb; 4(1):1-4. PubMed ID: 32128488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients.
    Morrow WR; Frazier EA; Mahle WT; Harville TO; Pye SE; Knecht KR; Howard EL; Smith RN; Saylors RL; Garcia X; Jaquiss RD; Woodle ES
    Transplantation; 2012 Feb; 93(3):319-24. PubMed ID: 22179403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient.
    Chehade H; Rotman S; Matter M; Girardin E; Aubert V; Pascual M
    Pediatrics; 2015 Feb; 135(2):e551-5. PubMed ID: 25624380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody.
    Ghirardo G; Benetti E; Poli F; Vidal E; Della Vella M; Cozzi E; Murer L
    Pediatr Transplant; 2014 Feb; 18(1):E1-5. PubMed ID: 24266980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T; Watarai Y; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Takeda A; Kobayashi T
    Transplant Proc; 2017; 49(1):159-162. PubMed ID: 28104125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation.
    Heo S; Park Y; Lee N; Kim Y; Kim YN; Shin HS; Jung Y; Rim H; Rennke HG; Chandraker A
    Transplant Proc; 2022 Oct; 54(8):2117-2124. PubMed ID: 36192209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children.
    Petit LM; Rabant M; Canioni D; Suberbielle-Boissel C; Goulet O; Chardot C; Lacaille F
    Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 28084679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ; Kamoun M; Chan KM
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.
    Kincaide E; Hitchman K; Hall R; Yamaguchi I; Ding Y; Crowther B
    Pediatr Transplant; 2019 Dec; 23(8):e13590. PubMed ID: 31617318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Anti-A/B Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplantation Treated With Bortezomib and Plasmapheresis: A Case Report.
    Lee JH; Lee H; Kim K; Lee SW; Song JH; Hwang SD
    Transplant Proc; 2022 Mar; 54(2):540-543. PubMed ID: 35067375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.
    Burbach M; Suberbielle C; Brochériou I; Ridel C; Mesnard L; Dahan K; Rondeau E; Hertig A
    Transplantation; 2014 Nov; 98(10):1056-9. PubMed ID: 24839895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Complement to Traditional Treatments for Antibody-Mediated Rejection? Use of Eculizumab in Lung Transplantation: A Review and Early Center Experience.
    Kleiboeker HL; Prom A; Paplaczyk K; Myers CN
    Ann Pharmacother; 2023 Nov; ():10600280231213112. PubMed ID: 37994573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options.
    Kim M; Martin ST; Townsend KR; Gabardi S
    Pharmacotherapy; 2014 Jul; 34(7):733-44. PubMed ID: 24753207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-Based Therapy in the Management of Antibody-Mediated Rejection.
    Bhalla A; Alachkar N; Alasfar S
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):138-148. PubMed ID: 32553246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Mediated Rejection Management Following Lung Transplantation.
    Neuhaus K; Hohlfelder B; Bollinger J; Haug M; Torbic H
    Ann Pharmacother; 2022 Jan; 56(1):60-64. PubMed ID: 33899550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.